State Medicaid agencies can improve D-SNP financial transparency and reward those D-SNPs that provide the best value to ...

We recently published a list of 10 Tech Stocks with High Upside Potential. In this article, we are going to take a look at ...

Synopsys SNPS shares plunged 20.8% over the past year, underperforming the Zacks Computer - Software industry, Zacks Computer ...

Synopsys (NASDAQ:SNPS – Free Report) had its price target decreased by Piper Sandler from $655.00 to $653.00 in a report released on Thursday,Benzinga reports. Piper Sandler currently has an ...

Stifel Nicolaus analyst Ruben Roy maintained a Buy rating on Synopsys (SNPS – Research Report) today and set a price target of $620.00. The ...

Despite a dip in overall revenue, Synopsys Inc (SNPS) sees growth in Design Automation and advances in AI-driven solutions.

This post was written by Luke Carberry Mogan. SNPS' first-quarter performance is likely to have benefited from the rising adoption of EDA, IP solutions and Synopsys.ai platform. Get a deeper ...

Would you like to be notified of the latest news and updates on the stock market?

Sigma Planning Corp decreased its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 4.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...

Synopsys SNPS delivered better-than-expected first-quarter fiscal 2025 results. The company reported non-GAAP earnings of $3.03 per share for the first quarter, surpassing the Zacks Consensus ...

Loop Capital Markets analyst Gary Mobley reiterated a Buy rating on Synopsys (SNPS – Research Report) today and set a price target of $650.00.

A comprehensive national study examining dementia patient outcomes for Medicare Advantage beneficiaries with Alzheimer's disease and related dementias (ADRD) uncovered key insights into healthcare ...